As of January 2026 Context Therapeutics has a market cap of A$0.22 Billion. This makes Context Therapeutics the world's 8870th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 10th, 2026 the market cap of Context Therapeutics was reported to be: